Mucus Clearance Devices – Focus on Homecare Settings
Inclination of the healthcare sector’s focus on a more patient-centric approach as health issues continue to become a major concern, and more entrepreneurs leverage the prevalence with innovating offerings that improve health outcomes. This will significantly rub off on demand for airway clearance products and mucus clearance devices, as the prevalence of chronic lung diseases continues to rise and shows no signs of abating.
Top 3 Factors Impacting the Growth of the Mucus Clearance Devices Market
Growing Popularity of PEP & OPEP Devices
Mucus clearance devices are considered medically necessary for the treatment of COPD, cystic fibrosis, bronchiectasis, and asthma. Increase in the number of requests about traveling with PEP machines internationally is boosting the global mucus clearance devices market. PEP is the standard therapy that is required, and it offers substantial health benefits when it is used as prescribed. Moreover, the launch of few mucus clearance devices, such as Aerobika, The Lung Flute, Flutter, Acapella, and others, has propelled the mucus clearance devices market. This has ultimately increased the popularity of PEP and OPEP devices, which is another factor that is expected to drive the revenue growth of the mucus clearance devices market over the forecast period
Increasing Focus of Companies Towards Homecare Settings
The providers of mucus clearance devices are primarily focusing on providing full service, which is likely to provide comprehensive information about a variety of respiratory disorders. Companies are more focused on maintaining a patient-centric culture. New products foster patient engagement with PEP, OPEP, and HFCWO therapy, which helps improve adherence to the prescribed treatment and better patient outcomes in homecare settings and clinics. The increasing usage of mucus clearance devices in home settings, technological assessments, changing healthcare guidelines, and the requirements of insurance payers are among the factors expected to significantly change the role of physicians, payers, and patients. Therefore, the increasing adoption of mucus clearance devices in homecare settings is expected to propel the mucus clearance devices market over the forecast period.
Rising Patient Pool Suffering from COPD
The Journal of Thoracic Disease reveals that approximately 3-4% of the population of China is suffering from COPD owing to high exposure to biomass smoke. A Study by WHO highlights that approximately 65 Mn people around the globe are suffering from COPD. The same study also estimates that this prevalence is expected to double by 2050. Furthermore, this study explains that high-income countries have greater prevalence owing to rising pollution. This factor is projected to drive the mucus clearance devices market.
Mucus Clearance Devices Market: Competitive Analysis
- The global mucus clearance devices market is highly consolidated, and the top five-six players are estimated to account for a market share of approximately 85%
- Hill-Rom Inc. accounted for a share of 35.3% of the global market in 2017 due to its focus on expansion in the emerging economies
- Allergan, Philips, Respiratory Technologies, Smiths Medical, and Electromed Inc. collectively accounted for a 49.3% share of the global mucus clearance devices market owing to the focus of these companies on key countries such as Brazil, India, Russia, China, and Mexico
- Other regional and local players, such as Westmed, Inc., International Biophysics Corp., Thayer Medical, and VORTRAN Medical, are estimated to gain the remaining revenue share of the mucus clearance devices market in 2017
Market Set to Grow 1.8X between 2018 and 2028
The palpable rise in mobile applications connected with respiratory devices, including the smart vest systems, continue to empower care providers, while telemedicine services apropos of mucus clearance have been gaining a notable traction. These aspects continue to propel development and adoption of mucus clearance devices.
Emerging Markets – Second Wave of Growth
Mucus clearance device sales show a remarkable rate in South Asia, East Asia, and Latin America, upheld by several macro trends that range from government focus on increasing the reimbursement support and customer care services, to sales force expansion efforts of the regional manufacturers and care providers.
* This data is only a representation. Actual data may vary and will be available in report.
The Broader Perspective
Stakeholders are shifting their production facilities to emerging economies in light of their ease access to resources and more lucrative market positioning of products, considering the latent growth potency of these nations.
HFCWO devices are the top-selling category, owing to the integration of various new features in recent years and rising demand from home care settings
OPEP devices will account for a significant share of mucus clearance devices market, owing to their better stimulation benefits.
MCA devices are also expected to witness notable demand in the assessment period
Mucus clearance devices continue to witness high sales in treatment of cystic fibrosis, accounting for nearly half market shares
COPD has been one of the most prevalent respiratory ailments, and sales of mucus clearance devices in its treatment have been traditionally high.
Gains from mucus clearance device sales in treatment of bronchiectasis will remain comparatively lower
Homecare settings continue to account for nearly 60% sales of mucus clearance devices
Hospitals will also account for significant market share, with sales estimated at over US$ 200 Mn
Mucus clearance devices sales in specialized clinics will grow at a comparatively higher rate
How Growth will Unfold
Prospects remain bullish for the mucus clearance devices landscape, attributed in part to the potential scope of combination therapies. Greater reliability and convenient reimbursement policies, along with the requirement for multiple devices in most high-risk patients, collectively allude high growth in adoption of combination therapies in the marketplace.
Specialized Clinics | Hospitals | Homecare Settings
* This data is only a representation. Actual data may vary and will be available in report.Click Here To Know How The Growth Will Unfold
Custom Market Research Services
FMI offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.
Mucus Clearance Devices: Global Industry Analysis 2013–2017 and Forecast 2018–2028
A recent market study published by FMI “Mucus Clearance Devices: Global Industry Analysis 2013–2017 and Forecast 2018–2028” offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historic as well as current growth parameters of the mucus clearance devices, the growth prospects of the market are obtained with maximum precision.
Mucus Clearance Devices Market Taxonomy
The global mucus clearance devices is segmented in detail to cover every aspect of the market and present a complete market intelligence approach in front of the reader.
By Cycle Type
- HFCWO Devices
- OPEP Devices
- MCA Devices
- IPV Devices
- PEP Devices
- Cystic Fibrosis
By End User
- Direct / Patient
- Fertility Clinics & IVF Centres
- North America
- Latin America
- South Asia
- East Asia
- Middle East & Africa
The report commences with the executive summary of the mucus clearance devices, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the mucus clearance devices.
Readers can find the detailed taxonomy and the definition of the mucus clearance devices in this chapter, which will help them understand the basic information about the mucus clearance devices. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the mucus clearance devices report.
This chapter explains the key macro-economic factors that are expected to influence the growth of the mucus clearance devices over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the mucus clearance devices. This chapter also highlights the key market dynamics of the mucus clearance devices, which include the drivers, restraints and trends. Moreover, readers will understand the key trends followed by the leading manufacturers in the mucus clearance devices.
This section includes the key inclusions of the report. It includes global Impact of Chronic Disease & Aging, Donor Cycle Mucus Clearance Techniques, Mucus Clearance Therapy, and Respiratory Therapist Driven Algorithm to Guide Mucus Clearance, Key Regulatory Status, FDA Approved mucus clearance devices and COPD Prevalence which could be necessary for the market.
This section explain the global market value analysis and forecast for the mucus clearance devices between the forecast periods of 2013-2027 is highlights in this section. This chapter includes the detailed analysis of the historical mucus clearance devices along with an opportunity analysis of the future. Readers can also find the absolute opportunity for the current year (2018 – 2019), and an incremental opportunity for the forecast period (2018 – 2019).
This section highlights the average price of HFCWO Devices, OPEP Devices, MCA Devices, IPV Devices and PEP Devices in the different region throughout the globe. The pricing benchmark for manufacturer level pricing and distributor level pricing is analyzed in this section.
Based on product Type, the mucus clearance devices is segmented into HFCWO devices, OPEP devices, MCA devices, IPV devices, and PEP devices. Readers can find information about the key trends and developments in the mucus clearance devices and market attractiveness analysis based on the product type.
Based on Indication, mucus clearance devices is segmented into Cystic Fibrosis, COPD, Bronchiectasis, and others. Readers can find information about the key trends and developments in the mucus clearance devices and market attractiveness analysis based on the Indication.
This chapter provides details about the mucus clearance devices on the basis of end user, and has been classified into Homecare Settings, Hospitals, Specialized Clinics, Rehabilitation Centres, and Ambulatory Surgical Centers. In this chapter, readers can understand the market attractive analysis based on end user.
This chapter explains how the mucus clearance devices will grow across various geographic regions, such as North America, Latin America, Europe, East Asia, South Asia, Oceania, the Middle East & Africa (MEA)
This chapter includes a detailed analysis of the growth of the North America North America, along with a country-wise assessment that includes the U.S. and Canada.
Readers can find detailed information about several factors, such as the pricing analysis, which are impacting the growth of the Latin America. This chapter also includes the growth prospects of the mucus clearance devices in the leading LATAM countries such as Brazil, Mexico, and the Rest of Latin America.
Important growth prospects of the mucus clearance devices based on its end users in several countries, such as Germany, the UK, France, Spain, Italy, Russia and the Rest of Europe, are included in this chapter.
India, Indonesia, Thailand, Malaysia are the leading countries in the South Asia region that are the prime subjects of assessment to obtain the growth prospects of the South Asia mucus clearance devices in this chapter. Readers can find detailed information about the growth parameters of the South Asia Mucus Clearance Devices during the period 2018–2028.
This chapter highlights the growth of the mucus clearance devices in the East Asia by focusing on China, Japan and South Korea. This section also helps readers understand the key factors that are responsible for the growth of the mucus clearance devices in East Asia.
In this chapter, Australia and New Zealand are among the leading countries in the Oceania region, which are the prime subjects of assessment to obtain the growth prospects of the Oceania mucus clearance devices.
This chapter provides information about how the mucus clearance devices will grow in the major countries in the MEA region, such as GCC Countries, South Africa, Turkey, Northern Africa and the rest of MEA, during the forecast period 2019 - 2029.
In this chapter, readers can find a detailed information about the tier analysis and market concentration of the key players in the mucus clearance devices along with their market presence analysis by region and product portfolio.
In this chapter, readers can find a comprehensive list of all the leading stakeholders in the mucus clearance devices, along with detailed information about each company, which includes the company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Hill-Rom Holdings, Inc., Allergan plc., Koninklijke Philips N.V., Smiths Medical, Inc., Electromed, Inc., VORTRAN Medical Technology, Monaghan Medical Corporation, Thayer Medical, Respiratory Technologies, Inc.
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the mucus clearance devices report.
This chapter helps readers understand the research methodology followed to obtain the various conclusions as well as important qualitative and quantitative information about the mucus clearance devices.
How the research was conducted?
- C - Level Executives
- Marketing Directors
- Sales Heads
- Portfolio Managers
- Purchasing Managers
- Medical Officers
- Device Development Heads
- Strategy Advisors
- R&D Managers
- Product Manufacturers
- Component Suppliers / OEMs
- Hospital Purchasing Departments
- Physicians / Nursing Managers
- Industry Experts
- Current Market Dynamics and Challenges
- Market Characteristics
- Market Performance and Growth Quadrants
- Competition Structure and Market Structure
- Strategic Growth Initiatives
- Product Adoption, Installed Base, Replacement Cycles, Refurbishment
- Regulatory Landscape
- Products in Pipeline and Clinical Development
- Near-term and Long-term Market Growth Prospects
- Market Segment Splits and Authenticity
- Opinions on Market Projections and Validity of Assumptions
- Industry Magazines
- COPD Foundation
- American Lung Association
- Cystic Fibrosis Foundation
- New Zealand Bronchiectasis Foundation
- American College of Chest Physicians
- Company Press Releases
- Annual Reports and Investor Presentations
- Peer-reviewed Journals
- Government Websites and Publications
- Trade Websites
- Clinical Trial Registries
- Country-specific Regulatory Authorities
World Bank, WHO, IMF, OECD
Primary Interview Splits